Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
BlackRock
New York
| $7.6B | +$1.33B | 90 | 0.17% | Increased |
|
| 2 |
Vanguard Group
Malvern,
Pennsylvania
| $6.82B | +$281M | 84 | 0.13% | Increased |
|
| 3 |
Fidelity Investments
Boston,
Massachusetts
| $3.51B | +$218M | 57 | 0.22% | Increased |
|
| 4 |
State Street
Boston,
Massachusetts
| $3.17B | +$276M | 81 | 0.14% | Increased |
|
| 5 |
SVGI
Sozo Ventures GP II
Redwood City,
California
| $2.37B | $0 | 1 | 90.78% | Maintained |
|
| 6 |
Morgan Stanley
New York
| $1.9B | +$195M | 93 | 0.15% | Increased |
|
| 7 |
Wellington Management Group
Boston,
Massachusetts
| $1.85B | -$202M | 35 | 0.33% | Reduced |
|
| 8 |
Janus Henderson Group
London,
| $1.76B | -$476M | 29 | 0.94% | Reduced |
|
| 9 |
T. Rowe Price Associates
Baltimore,
Maryland
| $1.68B | -$215M | 46 | 0.2% | Reduced |
|
| 10 |
Geode Capital Management
Boston,
Massachusetts
| $1.56B | +$150M | 94 | 0.14% | Increased |
|
| 11 |
Primecap Management
Pasadena,
California
| $1.41B | -$23.2M | 5 | 1.02% | Reduced |
|
| 12 |
Dimensional Fund Advisors
Austin,
Texas
| $1.33B | +$168M | 40 | 0.35% | Increased |
|
| 13 |
Dodge & Cox
San Francisco,
California
| $1.3B | -$11.8M | 1 | 0.78% | Reduced |
|
| 14 |
Bank of America
Charlotte,
North Carolina
| $1.21B | +$118M | 92 | 0.11% | Increased |
|
| 15 |
Capital International Investors
Los Angeles,
California
| $1.21B | -$146M | 5 | 0.25% | Reduced |
|
| 16 |
RTW Investments
New York
| $1.06B | -$190M | 11 | 16.43% | Reduced |
|
| 17 |
Avoro Capital Advisors
New York
| $1.04B | -$267M | 7 | 13.9% | Reduced |
|
| 18 |
Goldman Sachs
New York
| $1B | +$145M | 65 | 0.17% | Increased |
|
| 19 |
Bank of New York Mellon
New York
| $936M | +$207M | 55 | 0.18% | Increased |
|
| 20 |
Franklin Resources
San Mateo,
California
| $916M | -$23.5M | 27 | 0.28% | Reduced |
|
| 21 |
Farallon Capital Management
San Francisco,
California
| $851M | +$292M | 9 | 3.65% | Increased |
|
| 22 |
Kohlberg Kravis Roberts & Co
New York
| $787M | $0 | 1 | 23.6% | Maintained |
|
| 23 |
Northern Trust
Chicago,
Illinois
| $777M | +$21.2M | 78 | 0.13% | Increased |
|
| 24 |
JP Morgan Chase
New York
| $772M | -$2.28M | 80 | 0.06% | Reduced |
|
| 25 |
Invesco
Atlanta,
Georgia
| $767M | +$188M | 46 | 0.16% | Increased |
|